Latest Comments on Mark Barath's Articles

1. jeny09 on Cash Is King: Accrual Earnings Stock Screen: hey!! Thanks. Nice Info... more »
2. GrowthGuru on Buying Healthcare Stocks for an Obama Presidency (Part III): Assuming healthcare reform passes, the most likely scenario is... more »
3. balor123 on The Highest Yielding Cash Products: This is one area where stagflation sucks - virtually no matter... more »
4. us drugstore on Cash Is King: Accrual Earnings Stock Screen: Great peice thanks Intresting. more »
5. Jason Merriam on Cash Is King: Accrual Earnings Stock Screen: Aalan & Mark, The Merriam Report includes an accrual ratio model... more »
6. shostar on Stock Screen: Price Momentum + Fundamentals = Profits: These are some good stocks especially Thoratec. No doubt about... more »
7. Bull-y on Buying Healthcare Stocks for an Obama Presidency (Part III): I'm curious as to how any new healthcare company IPOing will pan... more »
8. madmax on The Top 10 Lowest Standard Deviation MLPs: AJ30, Here is some info from Humanevents.com link... more »
9. Bobcheesedoodle on The Top 10 Lowest Standard Deviation MLPs: AJ30, Partnerships are pass-through entities. As such, they are... more »
10. tipalia on Diageo Earnings Confirm the Long Case for Investors: wonderful company indeed,great ROE ,nice... more »
11. generic internist on Schering Plough, Merck: Potential Cancer Concerns : Too much information, released prematurely and mishandled by the... more »
12. AJ30 on The Top 10 Lowest Standard Deviation MLPs: Does anyone have any ideas on how Mr. Obamma's stated policy of... more »
13. Larry Bellehumeur on Diageo Earnings Confirm the Long Case for Investors: Mark -- Thanks for stealing my thunder, I was just finishing up on... more »
14. weiwentg on Diageo Earnings Confirm the Long Case for Investors: in response to Webisking, Altria also has potential legal... more »
15. johnnycanuck on Schering Plough, Merck: Potential Cancer Concerns : The sales of Vyotrin could get hit allot more if the investigation... more »